Matinas Biopharma Holdings IMTNB
13F holders, Q4 2024 (December 31)22holders +5
6new positions
3sold out
1famous investor
$0.53avg. 13F price*
At the end of Q4 2024, 22 institutions reported holding Matinas Biopharma Holdings I (MTNB) in their 13F filings, up 5 from Q3 2024. 6 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($54K), Sargent Investment Group, LLC ($38K) and BlackRock, Inc. ($25K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Matinas Biopharma Holdings I
- CUSIP
- 576810303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $22K |
| Exits | 3 | $536K |
All 13F filers, Q3 2024 → Q4 2024: 51,998 shares bought and 260,151 shares sold, net −208,153 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Vanguard Group Inc. | 0.00% | Reduce -42.9% | 106,494 | $54K |
| Sargent Investment Group, LLC | 0.01% | Reduce -20.0% | 64,200 | $38K |
| BlackRock, Inc. | 0.00% | No change | 49,650 | $25K |
| Geode Capital Management, LLC | 0.00% | Reduce -7.0% | 43,467 | $22K |
| Holos Integrated Wealth LLC | 0.01% | — | 32,480 | $17K |
| Susquehanna International Group, LLP | 0.00% | New | 23,802 | $12K |
| Renaissance Technologies | 0.00% | New | 18,170 | $9K |
| State Street Corp. | 0.00% | No change | 15,322 | $8K |
| UBS Group AG | 0.00% | Add +259.3% | 12,313 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,102 | $562 |
| Bank of America Corp. | 0.00% | Reduce -4.0% | 975 | $497 |
| JPMorgan Chase & Co. | 0.00% | Reduce -0.9% | 904 | $461 |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $101 |
| Morgan Stanley | 0.00% | Reduce -72.3% | 144 | $73 |
| Wells Fargo & Company | 0.00% | Reduce -90.7% | 102 | $52 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 60 | $31 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 61 | $31 |
| Rothschild Investment LLC | 0.00% | No change | 14 | $7 |
| SBI Securities Co., Ltd. | 0.00% | — | 11 | $6 |
| NewEdge Advisors, LLC | 0.00% | New | 1 | $1 |
| IFP Advisors, Inc | 0.00% | New | 2 | $1 |
| Royal Bank of Canada | 0.00% | New | 35 | $0 |
"% of holder's portfolio" is MTNB's weight in each manager's 13F, not the share of Matinas Biopharma Holdings I the manager owns.